-
Mashup Score: 4Ideas That Work: A Simple Fix for IV Pole Wheel Obstacles - 2 month(s) ago
Ideas That Work: A Simple Fix for IV Pole Wheel Obstacles; IV poles are critical for patient care, but these OR staples come with a major flaw: The wheels often become jammed and entangled with wires, creating a nuisance… Outpatient Surgery Magazine.
Source: www.aorn.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1ASH Presentations 2022 - 1 year(s) ago
Stanford BMT-CT ASH Abstracts 2022: Oral Abstracts 265 Precision-Engineered Cell Therapy Orca-T Demonstrates High Relapse-Free Survival at 1 Year While Reducing Graft-Versus-Host Disease and Toxicity Caspian Oliai, MD, MS1, Rasmus T Hoeg, MD2*, Anna Pavlova, MD, PhD3*, Arpita Gandhi, MD4, Lori Muffly, MD5, Rohtesh S. Mehta, MD6, Samer A Srour, MD, MS7, Edmund K. Waller, MD, PhD8, Robert Lowsky,…
Categories: Hem/Oncs, Latest HeadlinesTweet-
Looking forward to @ASH_hematology meeting and seeing the exciting and diverse work presented by @StanfordBMT_CT @StanfordCancer @StanfordDeptMed https://t.co/aFXchidtAd
-
-
Mashup Score: 0
With the St. Lawrence Quartet, he played with such enthusiasm that often he swept himself from his seat. At the Spoleto Festival USA, he was a shaping force.
Source: www.nytimes.comCategories: Hem/Oncs, Latest HeadlinesTweet-
One of the most beautiful people I will meet in my lifetime… sharing his gorgeous music here. Geoff Nuttall, First Among Equals in Acclaimed Quartet, Dies at 56 https://t.co/9P9CrGpAG9
-
-
Mashup Score: 0Law inspired by South Bay prosecutor’s leukemia experiences aims to expand marrow registry - 2 year(s) ago
‘Charlie’s Law’ will offer the option of joining the National Marrow Donor Program when Californians apply for driver’s licenses and ID cards.
Source: The Mercury NewsCategories: Hem/Oncs, Latest HeadlinesTweet-
Law inspired by South Bay prosecutor's leukemia experiences aims to expand marrow registry https://t.co/ChIiqEkTb2 so proud of this and of @CharlesHuangESQ and California! @StanfordBMT_CT
-
-
Mashup Score: 0Disparities in trial enrollment and outcomes of Hispanic adolescent and young adult acute lymphoblastic leukemia - 2 year(s) ago
Key Points. Contrary to population data, survival of Hispanic AYA ALL patients enrolled on CALGB 10403 was equivalent to non-Hispanic patients.Geographical alig
Source: American Society of HematologyCategories: Hem/Oncs, Latest HeadlinesTweet-
Very proud of this publication highlighting an unmet need in AYA ALL. Thank you @ALLIANCE_org @BloodAdvances @ASH_hematology https://t.co/ABBiERJTgs
-
-
Mashup Score: 10Stanford | Faculty Positions: Details - Assistant, Associate or Professor of Blood & Marrow Transplantation & Cellular Therapy - 2 year(s) ago
Assistant, Associate or Professor of Blood & Marrow Transplantation & Cellular Therapy Apply now Work type: University Medical Line, University Tenure Line Location: Stanford University Categories: School of Medicine The Department of Medicine, Division of Blood & Marrow Transplantation and Cellular Therapy (BMT-CT) seeks a physician scientist to be appointed as…
Source: facultypositions.stanford.eduCategories: Hem/Oncs, Latest HeadlinesTweet-
Stanford BMT-CT is hiring! We are looking for an enthusiastic clinical/translational researcher to join our faculty. Preference for clinical and/or research interest in myeloid malignancies. Please spread the word and contact me if interested! https://t.co/tFjlmMDIVB @ASTCT
-
-
Mashup Score: 2
Take this survey powered by surveymonkey.com. Create your own surveys for free.
Source: www.surveymonkey.comCategories: Hematologists1, Latest HeadlinesTweet-
6/🟢PRE Poll 3️⃣ #BonumCE #OncTwitter #MedTwitter 🟠#CME https://t.co/MUl2WlJTl3 🟢 Reduction in treatment intensity by omission of high-dose cytarabine from two cycles of of first-line therapy on the GRAAPH 2014 protocol for Ph+ ALL is associated with:
-
5/ 🟢PRE Poll 2️⃣ #BonumCE #OncTwitter #MedTwitter 🟠#CME https://t.co/MUl2WlJTl3 🟢 An exploratory analysis of the UKALL14 study found that patients with T-cell ALL with absence of biallelic TCR𝛄deletion (ABD) were associated with which of the following outcomes?
-
4/🟢PRE Poll 1️⃣ #BonumCE #OncTwitter #MedTwitter 🟠#CME https://t.co/MUl2WlJTl3 🟢 Which of the following is best describes outcomes associated with addition of 1 cycle nelarabine in adults with ALL based on the UKALL14 study?
-
-
Mashup Score: 0
Take this survey powered by surveymonkey.com. Create your own surveys for free.
Source: www.surveymonkey.comCategories: Hematologists1, Latest HeadlinesTweet-
11/🔴POST Poll 3️⃣ #MedTwitter #Webinar 🟠#CME https://t.co/jQrw3bMsTd 🔴 Reduction in treatment intensity by omission of high-dose cytarabine from two cycles of of first-line therapy on the GRAAPH 2014 protocol for Ph+ ALL is associated with:
-
10/🔴POST Poll2️⃣ #BonumCE #OncTwitter 🟠#CME https://t.co/jQrw3bMsTd 🔴 An exploratory analysis of the UKALL14 study found that patients with T-cell ALL with absence of biallelic TCR𝛄deletion (ABD) were associated with which of the following outcomes?
-
9/🔴POST Poll 1️⃣ #BonumCE #OncTwitter #MedTwitter 🟠#CME https://t.co/jQrw3bMsTd 🔴 Which of the following is best describes outcomes associated with addition of 1 cycle nelarabine in adults with ALL based on the UKALL14 study?
-
-
Mashup Score: 7
In order to address these educational needs, this CME-certified activity will focus on key studies presented at ASH 2021; including results from the Graaph-2014 (studied the omission of HD-AraC during consolidation of Ph-positive ALL patients treated with nilotinib and low-intensity chemotherapy) an
Source: Current ActivitiesCategories: Hematologists1, Latest HeadlinesTweet-
12/ ⚠️ Don’t forget to claim your 🆓 #CME @AmerMedicalAssn credit 🎫 https://t.co/A1WhTSz40N Thank you for joining our #ALL #leukemia CME series w/ @BonumCe 💕
-
3/ 🏆#CME credit provided by @IntegrityCE 🤝In partnership w/ @BonumCe ⏱️ Please answer! ⏱️ 🟢 PRE-polls before 💬 🔴POST-polls after 💬 🟠or🔗 https://t.co/A1WhTSz40N for #CME ℹ️ 👇CME info 👇 https://t.co/j8q5GjQwxX
-
2/🟠Get your 🆓 #CME CME ℹ️👉 https://t.co/A1WhTSz40N #MedTwitter #OncTwitter #leusm ✔️What are your credentials❓
-
🚥 #leukemia #ASH21 🛎️ Last call for poster #️5️ 〰️ Graaph-2014 study ➕ adding Nelarabine to chemo for #ALL pts 🔹 #OncTwitter w/ @LoriMuffly & @LuskinMarlise 🔸#CME from @BonumCe 🔗https://t.co/A1WhTSQESl 🔸Supported by edu grant Jazz Pharma https://t.co/W2TZi6C1IV
-
-
Mashup Score: 0
Take this survey powered by surveymonkey.com. Create your own surveys for free.
Source: www.surveymonkey.comCategories: Hem/Oncs, Latest HeadlinesTweet-
5/ 🟢PRE Poll 2️⃣ #BonumCE #OncTwitter #MedTwitter 🟠#CME https://t.co/5OKdt3GZfB 🟢Which of the following interventions was evaluated in attempt to improve both the efficacy and tolerability of therapy in the SWOG1318 study in elderly patients with Ph-ALL?
-
4/🟢PRE Poll 1️⃣ #BonumCE #OncTwitter #MedTwitter 🟠#CME https://t.co/5OKdt3YAEb 🟢In the 3 clinical trials reviewed (SWOG 1318, EWALL-INO and INITIAL-1), which of the following outcomes were observed in elderly patients with Ph-ALL?
-
Article | Outpatient Surgery Magazine wires away wheel guards keep wires away in the OR! @UCSFAnesthesia @IARS_Journals @UCSFAnesthesia @Stanford_obanes https://t.co/jzr1WfBT8a